Nearsightedness Clinical Trials

Find Nearsightedness Clinical Trials Near You

An Evaluation of Visual Comfort, Adaptation and Overall Satisfaction in Myopic Children Using A.M.L. Series of Lenses

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this research study is to understand the wearing experience of A.M.L. series of lenses in myopic children. The main questions it aims to answer are: * How quickly and effectively children adapt to the A.M.L. series of lenses? * The proportion of children who adapted to the A.M.L. series of lenses within 4 to 6 days? 40 myopic children aged 6 to 12 years will be recruited as participants, and all of them will be wearing A.M.L. series of lenses. Participants will: * Wear A.M.L. series of lenses for a period of 2 weeks * Visit at day 4-6, week 1 and week 2.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 12
Healthy Volunteers: f
View:

• Volunteer participant

• Informed consent of parent/guardian and assent of participant

• Age equal to or greater than 6 years and not older than 12 years at the time of signing informed consent and assent

• Spherical equivalent refraction (SER) by cycloplegic autorefraction equal or less than -0.50 D and equal or greater than -4.75D with astigmatism not more than 2.00 D on both eye

• Difference in SER (anisometropia) between two eyes should not exceed 1.50 D

• Best corrected visual acuity (BCVA) better than or equal to +0.10 LogMAR in each eye

• Be in good general health, based on the participant and the parent's/guardian's knowledge

• Willingness and ability to participate in study and comply with all scheduled visits

Locations
Other Locations
China
Shanghai Meishimeijing Ophthalmology Clinic Co., Ltd.
RECRUITING
Shanghai
Contact Information
Primary
Jiaoyan DU
du.jiaoyan@essilorchina.com
86+17696115308
Time Frame
Start Date: 2026-01-02
Estimated Completion Date: 2026-04-27
Participants
Target number of participants: 40
Treatments
Experimental: A.M.L. Series of Lenses
Related Therapeutic Areas
Sponsors
Leads: Essilor International

This content was sourced from clinicaltrials.gov

Similar Clinical Trials